Nio Shares Surge on Launch of First Flagship SUV in Over Two Years Five Indian Sectors Hit 52Week Highs Amid Geopolitical Tensions Pharma Energy Defence Capital Markets Metals Show Strength HRS Aluglaze Shares Surge After Strong FY26 Results Revenue Jumps Over 60 UK Police Chiefs Call for Blocking Unsafe Social Media for Under16s Potentially Reshaping Platform Regulations ATTs BlueCollar Workforce Challenge Highlights AI Economys Shift in American Dream Assessing Expectations for the April Jobs Report GNLX Q1 2026 Earnings EPS Misses Estimates as Company Reports No Revenue LTH Q1 2026 Earnings Strong EPS Beat Fails to Lift Shares KRMD Q1 2026 Earnings NarrowerThanExpected Loss Amid Flat Revenue Visibility Beyond Air Inc XAIR Q1 2026 Earnings Narrowed Loss Slightly Exceeds Expectations as Clinical Pipeline Advances AREB Q1 2026 Earnings Significant Loss Reported Stock Falls 138 QFIN Q4 2025 Earnings EPS Miss Triggers Share Price Decline McEwen Inc MUX Declines 257 as Gold Stocks Face Pressure Support at 2038 in Focus BEPI Holds Steady Near Midpoint of Key Range Brookfield BRP Holdings Perpetual Notes Flat at 1562 Republic Power Group Limited RPGL Surges Support Holds Firm at 028 UMH Properties Edges Higher as Stock Approaches Key Resistance Level Pegasystems Inc PEGA Holds Steady Near Resistance as Volume Remains Moderate General Dynamics Outlook Raised by SP on Strong Credit Metrics Airgain Q1 2026 Earnings EPS Misses Estimates as Cost Pressures Weigh Bicara Therapeutics BCAX Edges Lower Traders Watch Support Near 2069 UNIT Q1 2026 Earnings EPS Surprises with a 296 Beat Amid Narrowing Losses Stock Declines META Q1 2026 Earnings EPS Beat by 56 Drives Positive Market Reaction NKSH Q4 2025 Earnings Earnings Surprise of 2111 Driven by Strong Operating Performance Imperial Oil Q1 2026 Earnings Earnings Miss Amid Weaker Upstream Margins RDVT Q1 2026 Earnings Strong EPS Beat Drives Positive Stock Reaction SRPT Q1 2026 Earnings EPS Smashes Estimates by 1847 as Gene Therapy Execution Drives Profit Surprise NGNE Q1 2026 Earnings EPS Misses Estimates as Biotech Continues RD Focus